GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Jul 2012 06:26 PM
RNS
Director/PDMR Shareholding
17 Jul 2012 03:38 PM
RNS
Director/PDMR Shareholding
16 Jul 2012 02:15 PM
RNS
GSK to acquire HGS for $14.25 per share in cash
12 Jul 2012 05:53 PM
RNS
Director/PDMR Shareholding
12 Jul 2012 05:51 PM
RNS
Director/PDMR Shareholding
12 Jul 2012 05:47 PM
RNS
Director/PDMR Shareholding
11 Jul 2012 04:00 PM
RNS
GSK announces positive data from Harmony 8 study
11 Jul 2012 03:58 PM
RNS
Director/PDMR Shareholding
11 Jul 2012 03:56 PM
RNS
Director/PDMR Shareholding
11 Jul 2012 07:00 AM
RNS
Positive data for dolutegravir vs Atripla
10 Jul 2012 05:49 PM
RNS
Director/PDMR Shareholding
10 Jul 2012 05:47 PM
RNS
Director/PDMR Shareholding
10 Jul 2012 05:46 PM
RNS
Director/PDMR Shareholding
10 Jul 2012 05:44 PM
RNS
Director/PDMR Shareholding
10 Jul 2012 02:42 PM
RNS
Director/PDMR Shareholding
09 Jul 2012 03:37 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 06:03 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 05:22 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 05:02 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 04:01 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 03:57 PM
RNS
Director/PDMR Shareholding
02 Jul 2012 03:42 PM
RNS
GSK concludes settlement with US Government
02 Jul 2012 03:11 PM
RNS
Director/PDMR Shareholding
02 Jul 2012 12:18 PM
RNS
Total Voting Rights
02 Jul 2012 07:00 AM
RNS
GSK announces Ph III data for LABA/LAMA in COPD
29 Jun 2012 12:00 PM
RNS
GSK sets expiration of tender offer to acquire HGS
28 Jun 2012 05:26 PM
RNS
Transaction in Own Shares
27 Jun 2012 05:43 PM
RNS
Transaction in Own Shares
26 Jun 2012 05:50 PM
RNS
Transaction in Own Shares
26 Jun 2012 03:03 PM
RNS
GSK publish 2011 core operating profit by segment
25 Jun 2012 05:23 PM
RNS
Transaction in Own Shares
25 Jun 2012 04:42 PM
RNS
Director/PDMR Shareholding
22 Jun 2012 05:23 PM
RNS
Transaction in Own Shares
21 Jun 2012 05:13 PM
RNS
Transaction in Own Shares
20 Jun 2012 05:37 PM
RNS
Transaction in Own Shares
19 Jun 2012 05:35 PM
RNS
Transaction in Own Shares
18 Jun 2012 05:11 PM
RNS
Transaction in Own Shares
15 Jun 2012 05:25 PM
RNS
Transaction in Own Shares
15 Jun 2012 03:03 PM
RNS
GSK continues with tender offer to acquire HGS
14 Jun 2012 05:14 PM
RNS
Transaction in Own Shares
14 Jun 2012 04:56 PM
RNS
Director/PDMR Shareholding
14 Jun 2012 04:48 PM
RNS
Director/PDMR Shareholding
13 Jun 2012 05:52 PM
RNS
Transaction in Own Shares
12 Jun 2012 05:21 PM
RNS
Transaction in Own Shares
12 Jun 2012 07:00 AM
RNS
GSK signs worldwide acquisition for Toctino
11 Jun 2012 05:46 PM
RNS
Transaction in Own Shares
11 Jun 2012 04:33 PM
RNS
Director/PDMR Shareholding
08 Jun 2012 05:46 PM
RNS
Transaction in Own Shares
08 Jun 2012 01:30 PM
RNS
GSK extends tender offer for shares of HGS
07 Jun 2012 05:06 PM
RNS
Transaction in Own Shares

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings